Alert type: Public advisory
Category: Health products - Drugs
Product: Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths
Issue: Health products - Contamination
What to do: Contact your health care provider to discuss other treatment options. While there are no other companies marketing extended release propranolol in Canada, immediate release propranolol products continue to be available, along with other treatment options. Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition poses a greater health risk.
Audience: General public
We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.
Get health product recall alertsCA$3.99/mo · cancel anytime
| DIN | Product | Lot | Expiry |
|---|
| 02042266 | Inderal-LA 120 mg | FE0541 | 2024-01-31 |
| 02042266 | Inderal-LA 120 mg | EH5908 | 2023-08-31 |
| 02042258 | Inderal-LA 80 mg | DW8242 | 2023-03-31 |
| 02042258 | Inderal-LA 80 mg | DJ2768 | 2022-09-30 |
| 02042258 | Inderal-LA 80 mg | EL1695 | 2023-08-31 |
| 02042258 | Inderal-LA 80 mg | EE7221 | 2023-05-31 |
| 02042231 | Inderal-LA 60 mg | DX6150 | 2023-03-31 |
| 02042266 | Inderal-LA 120 mg | DJ6820 | 2022-09-30 |
| 02042274 | Inderal-LA 160 mg | FE6304 | 2024-01-31 |
| 02042258 | Inderal-LA 80 mg | EX7462 | 2024-01-31 |
| 02042231 | Inderal-LA 60 mg | EX7461 | 2024-01-31 |
| 02042274 | Inderal-LA 160 mg | EH5906 | 2023-08-31 |
| 02042274 | Inderal-LA 160 mg | DW8241 | 2023-03-31 |
| 02042231 | Inderal-LA 60 mg | EH5907 | 2023-08-31 |
| 02042266 | Inderal-LA 120 mg | DX6159 | 2023-03-31 |